Unknown

Dataset Information

0

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years.


ABSTRACT: Influenza outbreaks caused by A/H7N9 viruses have occurred since 2013. After 2016, A/H7N9 influenza viruses underwent evolutionary changes. In this study, we examined the antigenic properties of influenza neuraminidase (NA) of A/H7N9 viruses as part of a live influenza vaccine (LAIV). It was shown that neuraminidase inhibiting (NI) antibodies obtained after A/Anhui/1/2013(H7N9)-based LAIV vaccination did not inhibit A/Hong Kong/125/2017(H7N9) NA and vice versa. The A/Hong Kong/125/2017(H7N9)-based LAIV elicited higher levels of NI antibodies compared to the A/Anhui/1/2013(H7N9)-based LAIV after two doses. Thelow degree of coincidence of the antibody response to hemagglutinin (HA) and NA after LAIV vaccination allows us to consider an enzyme-linked lectin assay (ELLA) as an additional measure for assessing the immunogenicity of influenza vaccines. In mice, N9-reactive monoclonal antibodies (mABs) for the A/environment/Shanghai/RL01/2013(H7N9) influenza virus partially protected against lung infection from the A/Guangdong/17SF003/2016 IDCDC-RG56N(H7N9) virus, thus showing the cross-protective properties of monoclonal antibodies against the drift variant.

SUBMITTER: Desheva Y 

PROVIDER: S-EPMC9503534 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years.

Desheva Yulia Y   Losev Igor I   Petkova Nadezhda N   Kudar Polina P   Donina Svetlana S   Mamontov Andrey A   Tsai Chih-Hsuan CH   Chao Yu-Chan YC  

Pharmaceuticals (Basel, Switzerland) 20220909 9


Influenza outbreaks caused by A/H7N9 viruses have occurred since 2013. After 2016, A/H7N9 influenza viruses underwent evolutionary changes. In this study, we examined the antigenic properties of influenza neuraminidase (NA) of A/H7N9 viruses as part of a live influenza vaccine (LAIV). It was shown that neuraminidase inhibiting (NI) antibodies obtained after A/Anhui/1/2013(H7N9)-based LAIV vaccination did not inhibit A/Hong Kong/125/2017(H7N9) NA and vice versa. The A/Hong Kong/125/2017(H7N9)-bas  ...[more]

Similar Datasets

| S-EPMC3891892 | biostudies-literature
| S-EPMC4351886 | biostudies-literature
| S-EPMC7392412 | biostudies-literature
| S-EPMC8540337 | biostudies-literature
| S-EPMC6062064 | biostudies-literature
| S-EPMC3251064 | biostudies-literature
| S-EPMC4585053 | biostudies-literature
| S-EPMC10027924 | biostudies-literature
| S-EPMC10705590 | biostudies-literature
| S-EPMC7262163 | biostudies-literature